Point-of-care diagnosis of COVID-19 disease based on antigen tests

Insights

Point-of-care antigen tests for diagnosing SARS-CoV-2, the virus that causes COVID-19, are rapidly improving. These small, hand-held diagnostic tools offer growing potential for widespread, accessible COVID-19 detection.

Area of Science:

  • Medical Diagnostics
  • Virology
  • Biotechnology

Background:

  • The COVID-19 pandemic necessitated rapid development of diagnostic tools.
  • Accurate and accessible laboratory diagnosis of SARS-CoV-2 is crucial for disease control.
  • Antigen detection assays are a key area of focus for COVID-19 diagnostics.

Purpose of the Study:

  • To review laboratory diagnostic methods for COVID-19 focusing on SARS-CoV-2 antigen detection.
  • To analyze the current landscape and development of various antigen testing technologies.
  • To provide a comprehensive overview of antigen-based diagnostic approaches.

Main Methods:

  • A comprehensive literature survey of recent publications (2019-2021) was conducted.
  • Relevant papers on COVID-19 antigen tests were critically discussed and cited.
  • Specifications of antigen tests and comparative diagnostic methods were examined.

Main Results:

  • Lateral flow tests and biosensors are identified as key tools for COVID-19 diagnosis.
  • The application of these tests in point-of-care settings is a significant consideration.
  • Development trends indicate improvements in diagnostic value and applicability.

Conclusions:

  • Point-of-care, small hand-held assays for SARS-CoV-2 antigen detection are of increasing interest.
  • These assays are undergoing significant development to enhance their performance.
  • The study discusses the merits and practical applicability of these evolving diagnostic tools.
Abstract